| Impaired barrier function in patients with house dust mite–induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression B Steelant, R Farré, P Wawrzyniak, J Belmans, E Dekimpe, H Vanheel, ... Journal of Allergy and Clinical Immunology 137 (4), 1043-1053. e5, 2016 | 295 | 2016 |
| Epithelial barriers in allergy and asthma PW Hellings, B Steelant Journal of Allergy and Clinical Immunology 145 (6), 1499-1509, 2020 | 232 | 2020 |
| Histamine and T helper cytokine–driven epithelial barrier dysfunction in allergic rhinitis B Steelant, SF Seys, L Van Gerven, M Van Woensel, R Farré, ... Journal of Allergy and Clinical Immunology 141 (3), 951-963. e8, 2018 | 183 | 2018 |
| Endotype-driven treatment in chronic upper airway diseases G De Greve, PW Hellings, WJ Fokkens, B Pugin, B Steelant, SF Seys Clinical and translational allergy 7, 1-14, 2017 | 180 | 2017 |
| Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration M Van Woensel, N Wauthoz, R Rosière, V Mathieu, R Kiss, F Lefranc, ... Journal of Controlled Release 227, 71-81, 2016 | 151 | 2016 |
| TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells YA Alpizar, B Boonen, A Sanchez, C Jung, A López-Requena, R Naert, ... Nature communications 8 (1), 1059, 2017 | 107 | 2017 |
| Occupational upper airway disease: how work affects the nose V Hox, B Steelant, W Fokkens, B Nemery, PW Hellings Allergy 69 (3), 282-291, 2014 | 95 | 2014 |
| Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis B Steelant, P Wawrzyniak, K Martens, AC Jonckheere, B Pugin, ... Journal of Allergy and Clinical Immunology 144 (5), 1242-1253. e7, 2019 | 91 | 2019 |
| Probiotics for the airways: potential to improve epithelial and immune homeostasis K Martens, B Pugin, I De Boeck, I Spacova, B Steelant, SF Seys, S Lebeer, ... Allergy 73 (10), 1954-1963, 2018 | 83 | 2018 |
| Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease B Steelant, SF Seys, G Boeckxstaens, CA Akdis, JL Ceuppens, ... Rhinology 54 (3), 195-205, 2016 | 83 | 2016 |
| Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden M Doulaptsi, E Prokopakis, S Seys, B Pugin, B Steelant, P Hellings Clinical and Translational Allergy 8, 1-6, 2018 | 71 | 2018 |
| Nasal hyperreactivity in rhinitis: A diagnostic and therapeutic challenge L Van Gerven, B Steelant, PW Hellings Allergy 73 (9), 1784-1791, 2018 | 70 | 2018 |
| MP 29‐02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite‐allergic rhinitis I Kortekaas Krohn, I Callebaut, YA Alpizar, B Steelant, L Van Gerven, ... Allergy 73 (5), 1084-1093, 2018 | 57 | 2018 |
| EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis PW Hellings, CA Akdis, C Bachert, J Bousquet, B Pugin, G Adriaensen, ... Rhinology 55 (3), 202-210, 2017 | 55 | 2017 |
| Anterior nares diversity and pathobionts represent sinus microbiome in chronic rhinosinusitis I De Boeck, S Wittouck, K Martens, J Claes, M Jorissen, B Steelant, ... MSphere 4 (6), 10.1128/msphere. 00532-19, 2019 | 50 | 2019 |
| Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation I Kortekaas Krohn, SF Seys, G Lund, AC Jonckheere, ... Allergy 75 (5), 1155-1164, 2020 | 48 | 2020 |
| Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrity K Martens, SF Seys, YA Alpizar, R Schrijvers, DMA Bullens, C Breynaert, ... Clinical & Experimental Allergy 51 (1), 87-98, 2021 | 43 | 2021 |
| Enhanced chemosensory sensitivity in patients with idiopathic rhinitis and its reversal by nasal capsaicin treatment L Van Gerven, YA Alpizar, B Steelant, I Callebaut, IK Krohn, M Wouters, ... Journal of Allergy and Clinical Immunology 140 (2), 437-446. e2, 2017 | 41 | 2017 |
| Airway basal cells, protectors of epithelial walls in health and respiratory diseases E Ruysseveldt, K Martens, B Steelant Frontiers in Allergy 2, 787128, 2021 | 36 | 2021 |
| Programmed cell death‐1 expression correlates with disease severity and IL‐5 in chronic rhinosinusitis with nasal polyps I Kortekaas Krohn, S Bobic, J Dooley, F Lan, N Zhang, C Bachert, ... Allergy 72 (6), 985-993, 2017 | 29 | 2017 |
Yeranddy A AlpizarRega Institute KU LeuvenVerified email at kuleuven.be
